243 related articles for article (PubMed ID: 21849157)
1. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients.
Pompilio A; Scocchi M; Pomponio S; Guida F; Di Primio A; Fiscarelli E; Gennaro R; Di Bonaventura G
Peptides; 2011 Sep; 32(9):1807-14. PubMed ID: 21849157
[TBL] [Abstract][Full Text] [Related]
2. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
[TBL] [Abstract][Full Text] [Related]
3. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.
Saiman L; Tabibi S; Starner TD; San Gabriel P; Winokur PL; Jia HP; McCray PB; Tack BF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2838-44. PubMed ID: 11557478
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections.
Mardirossian M; Pompilio A; Crocetta V; De Nicola S; Guida F; Degasperi M; Gennaro R; Di Bonaventura G; Scocchi M
Amino Acids; 2016 Sep; 48(9):2253-60. PubMed ID: 27270571
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
[TBL] [Abstract][Full Text] [Related]
8. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
9. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
Rutter WC; Burgess DR; Burgess DS
Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.
Wnorowska U; Niemirowicz K; Myint M; Diamond SL; Wróblewska M; Savage PB; Janmey PA; Bucki R
Antimicrob Agents Chemother; 2015 Jul; 59(7):3808-15. PubMed ID: 25870055
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum.
Sambri V; Marangoni A; Giacani L; Gennaro R; Murgia R; Cevenini R; Cinco M
J Antimicrob Chemother; 2002 Dec; 50(6):895-902. PubMed ID: 12461010
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2.
Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC
Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756
[TBL] [Abstract][Full Text] [Related]
14. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
16. Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils.
Xie F; Zan Y; Zhang X; Zhang H; Jin M; Zhang W; Zhang Y; Liu S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182913
[TBL] [Abstract][Full Text] [Related]
17. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.
Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164
[TBL] [Abstract][Full Text] [Related]
18. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
Wu K; Yau YC; Matukas L; Waters V
Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus.
Dean SN; Bishop BM; van Hoek ML
BMC Microbiol; 2011 May; 11():114. PubMed ID: 21605457
[TBL] [Abstract][Full Text] [Related]
20. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]